IMIST


Primer on multiple sclerosis (notice n° 16278)

000 -LEADER
fixed length control field 01742nam a2200241 u 4500
001 - CONTROL NUMBER
control field UNI0000318
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161124101556.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 131107s2010 XX eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0195369289 (paperback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780195369281 (paperback)
040 ## - CATALOGING SOURCE
Original cataloging agency DCLC
040 ## - CATALOGING SOURCE
Modifying agency IMIST
Description conventions AFNOR
041 1# - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.834
Edition number 22
245 #0 - TITLE STATEMENT
Title Primer on multiple sclerosis
Statement of responsibility, etc Barbara S. Giesser MD.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc [S.l.]
Name of publisher, distributor, etc Oxford University Press, USA
Date of publication, distribution, etc 2010.
300 ## - PHYSICAL DESCRIPTION
Extent 504 p.
Dimensions 26 cm.
500 ## - GENERAL NOTE
General note Primer on Multiple Sclerosis was developed to provide a comprehensive overview of the clinical and basic science aspects of MS. It is designed to be of practical use to clinical neurologists, and addresses all of the major issues that may occur in the management of persons with MS. The reader is provided with the latest information on the science of MS, including immunology, genetics, epidemiology and pathology, as well as a summary of the newest directions in basic science research. Guidelines for diagnosis and appropriate use of diagnostic modalities are presented. All clinical aspects of MS are discussed, including extensive information on aspects that may be more challenging for the neurologist to manage, such as sleep disorders and pain. Disease modifying therapies, including those that are FDA approved, as well as off label and experimental therapies are discussed. Finally, there are chapters on employment and legal issues, as well as an overview of clinical trials and clinical trial outcome measures, which are helpful in reviewing the scientific literature in these areas.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Multiple sclerosis
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Multiple sclerosis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giesser, Barbara S.
Exemplaires
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
        La bibliothèque des Sciences Médicales et Pharmaceutiques La bibliothèque des Sciences Médicales et Pharmaceutiques   19787   616.834 GIE 0000000020115 11/24/2016 11/24/2016 Livre
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha